Cart summary

You have no items in your shopping cart.

PKR-IN-C16

SKU: orb1219493

Description

PKR-IN-C16 is a specific protein kinase (PKR) inhibitor. PKR-IN-C16 is able to inhibit the autophosphorylation of PKR and unlock the translation blockade induced by PKR in primary neuronal cultures.PKR-IN-C16 binds the ATP-binding site of PKR and blocks autophosphorylation with an IC50 value of 186-210 nM. PKR-IN-C16 protects human neuroblastoma cells against cell damage triggered by tunicamycin-mediated endoplasmic reticulum stress.

Images & Validation

Key Properties

CAS Number608512-97-6
MW268.29
Purity>98% (HPLC)
FormulaC13H8N4OS
SMILESO=C1Nc2ccc3ncsc3c2\C1=C\c1cnc[nH]1
TargetPKR
SolubilityDMSO:15.67 mg/mL(58.41 mM)

Bioactivity

In Vivo
PKR-IN-C16 (Compound C16) (60 or 600 μg/kg; i.p.; 3 times) prevents not only the PKR-induced neuronal loss but also the inflammatory response in the Quinolinic acid (QA) (HY-100807) induced acute excitotoxic rat model. Animal model: Normotensive male Wistar rats, excitotoxic neuroinflammatory model, inflammation was induced by unilateral striatal injection of quinolinic acid (QA). Dosage: 60 or 600 μg/kg. Administration: Intraperitoneal injection; 24 h, 2 h before QA injection and 24 h post-QA injection. Result: Reduced expression of the active catalytic domain of the PKR, prevented increase of IL-1β levels on the contralateral side (97% inhibition) at 600 μg/kg. Decreased by 47% the neuronal loss and by 37% the number of positive cleaved caspase-3 neurons induced by QA injection at 600 μg/kg.
In Vitro
PKR-IN-C16 (Compound C16) is able to unlock the translation blockade induced by PKR in primary neuronal cultures. PKR-IN-C16 (0.1 or 0.3 μM; 24 h) shows protective effect against the neuronal cell death induced by endoplasmic reticulum stress in SH-SY5Y cells. PKR-IN-C16 (1-1000 nM; 4 h) prevents not only PKR-phosphorylation but also the activation of caspase-3 induced by Amyloid β in SH-SY5Y cells. Western blot analysis. Cell line: Human SH-SY5Y cells. Concentration: 1, 10, 20, 200, 1000 nM. Incubation time: 4 h. Result: Markedly reduces the level of phosphorylated PKR in the cells exposed to 20 μM Amyloid β.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • PKR-IN-C16 [orb1307866]

    99.48% (May vary between batches)

    608512-97-6

    268.29

    C13H8N4OS

    1 mg, 5 mg, 10 mg, 25 mg, 100 mg, 50 mg, 1 ml x 10 mM (in DMSO), 2 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

PKR-IN-C16 (orb1219493)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

200 mg
500 mg
2 mg
$ 100.00
5 mg
$ 140.00
10 mg
$ 210.00
25 mg
$ 400.00
50 mg
$ 610.00
100 mg
$ 890.00